A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma.
Journal Information
Full Title: Cancer Control
Abbreviation: Cancer Control
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."
"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research reported in this publication was supported in part by the National Cancer Institute of the National Institutes of Health under award number P30CA062203 and the UC Irvine Anti-Cancer Challenge Grant Center using UCI Anti-Cancer Challenge funds. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Chao Family Comprehensive Cancer Center."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025